New Opportunities & Implications For The Future Of Drug Development In Emerging Economies

Ed Mills, Cytel’s Vice President of Real World Evidence hosts a panel on how COVID-19 is affecting access to drug development and equitable medical care in emerging economies. How can the private sector support these initiatives while seeking worthwhile opportunities for long term growth? Ed is joined by Trevor Mundel, who is currently serving as President of the Bill & Melinda Gates Foundation, as well as James Orbinski, President Emeritus of Medecins Sans Frontiers, Robin Mogg of the Bill & Melinda Gates Research Institute, and Derek Angus of the groundbreaking the REMAP-CAP and Crown Coronation Trials.